Insider Transactions in Q3 2022 at Transcode Therapeutics, Inc. (RNAZ)

RNAZ Quotes by TradingView

Insider Transaction List (Q3 2022)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Sep 14 2022
Robert Michael Dudley Chief Executive Officer
BUY
Open market or private purchase
Direct
20,000 +2.19%
$20,000 $1.15 P/Share

Track Institutional and Insider Activities on RNAZ

Follow Transcode Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNAZ shares.

Notify only if

Insider Trading

Get notified when an Transcode Therapeutics, Inc. insider buys or sells RNAZ shares.

Notify only if

News

Receive news related to Transcode Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RNAZ